Clinical studies have consistently demonstrated that higher-dose semaglutide treatments lead to significantly greater weight loss outcomes compared to lower-dose options (such as Ozempic)
Additionally, metformin reduced HbA1c by 1.5% (16 mmol/mol) and fasting blood glucose by approximately 3.1 mmol/L when titrated to 2000 mg/day for 6 months
Practical strategies to minimize hypotension risk include: Adequate hydration: Maintain consistent fluid intake throughout the day based on individual needs and medical conditions (consult your provider for personalized recommendations, especially if you have heart failure or kidney disease) Gradual position changes: Rise slowly from lying to sitting, then sitting to standing, pausing between transitions Dietary sodium: Unless contraindicated, maintain adequate sodium intake as directed by your healthcare provider Compression stockings: Knee-high or thigh-high compression garments (20-30 mmHg) may help prevent blood pooling
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), particularly semaglutide, have emerged as potent therapeutic agents for both T2DM and obesity
Find out about Ozempic for weight loss and if it really works
The pages on Trulicity and Weight Loss, Victoza Weight Loss, and Semaglutide Weight Loss can help frame questions for a clinician
